{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:36:11Z","timestamp":1787502971271,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["QJRC2022028"],"award-info":[{"award-number":["QJRC2022028"]}],"id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["LH202402044"],"award-info":[{"award-number":["LH202402044"]}],"id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232322"],"award-info":[{"award-number":["7232322"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.phymed.2025.156651","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:43:41Z","timestamp":1744303421000},"page":"156651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Preclinical evidence construction for epigallocatechin-3-gallate against non-alcoholic fatty liver disease: a meta-analysis and machine learning study"],"prefix":"10.1016","volume":"142","author":[{"given":"Yuanhao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6320-7222","authenticated-orcid":false,"given":"Tingyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-0369","authenticated-orcid":false,"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phymed.2025.156651_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2024.102986","article-title":"Role of angiotensin II in non-alcoholic steatosis development","volume":"55","author":"Alvarado-Ojeda","year":"2024","journal-title":"Arch. Med. Res."},{"issue":"3","key":"10.1016\/j.phymed.2025.156651_bib0002","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1142\/S0192415X18500325","article-title":"Epigallocatechin-3-gallate-rich green tea extract ameliorates fatty liver and weight gain in mice fed a high fat diet by activating the sirtuin 1 and AMP activating protein kinase pathway","volume":"46","author":"Bae","year":"2018","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phymed.2025.156651_bib0003","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/DDDT.S180079","article-title":"Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives","volume":"13","author":"Bimonte","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.phymed.2025.156651_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.111086","article-title":"The influence of angiotensin II and RAAS blockers on lipolytic and glycolytic activity in isolated adipocytes from Wistar, Wistar-Kyoto and Spontaneously Hypertensive Rats","volume":"520","author":"Borghi","year":"2021","journal-title":"Mol. Cell Endocrinol."},{"issue":"8","key":"10.1016\/j.phymed.2025.156651_bib0005","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"1 Suppl","key":"10.1016\/j.phymed.2025.156651_bib0006","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156651_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700483","article-title":"Potential biological effects of (-)-epigallocatechin-3-gallate on the treatment of nonalcoholic fatty liver disease","volume":"62","author":"Chen","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phymed.2025.156651_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155585","article-title":"Oxysophoridine inhibits oxidative stress and inflammation in hepatic fibrosis via regulating Nrf2 and NF-\u03bab pathways","volume":"132","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.156651_bib0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biopha.2015.12.013","article-title":"Protective role of epigallocatechin-3-gallate in health and disease: a perspective","volume":"78","author":"Chowdhury","year":"2016","journal-title":"Biomed. PharmacOther"},{"issue":"1","key":"10.1016\/j.phymed.2025.156651_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s11658-024-00631-4","article-title":"Paeoniflorin protects hepatocytes from APAP-induced damage through launching autophagy via the MAPK\/mTOR signaling pathway","volume":"29","author":"Deng","year":"2024","journal-title":"Cell. Mol. Biol Lett."},{"key":"10.1016\/j.phymed.2025.156651_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108455","article-title":"Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota","volume":"84","author":"Dey","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phymed.2025.156651_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1148814","article-title":"Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis","volume":"14","author":"Ding","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.156651_bib0012","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejphar.2015.05.005","article-title":"Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet","volume":"761","author":"Ding","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phymed.2025.156651_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020599","article-title":"Epigallocatechin-3-gallate dampens non-alcoholic fatty liver by modulating liver function, lipid profile and macrophage polarization","volume":"13","author":"Du","year":"2021","journal-title":"Nutrients."},{"key":"10.1016\/j.phymed.2025.156651_bib0014","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jep.2017.08.035","article-title":"Molecular understanding of epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases","volume":"210","author":"Eng","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.phymed.2025.156651_bib0015","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"10.1016\/j.phymed.2025.156651_bib0016","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.phymed.2025.156651_bib0017","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/aps.2015.11","article-title":"Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice","volume":"36","author":"Gan","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"Pt B","key":"10.1016\/j.phymed.2025.156651_bib0018","article-title":"Chinese herbal medicines: the modulator of nonalcoholic fatty liver disease targeting oxidative stress","volume":"318","author":"Gong","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2025.156651_bib0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phymed.2025.156651_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC. Med. Res. Methodol."},{"issue":"5","key":"10.1016\/j.phymed.2025.156651_bib0021","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5650\/jos.ess19303","article-title":"Epigallocatechin gallate suppresses inflammatory responses by inhibiting toll-like receptor 4 signaling and alleviates insulin resistance in the livers of high-fat-diet rats","volume":"69","author":"Hou","year":"2020","journal-title":"J. Oleo Sci."},{"key":"10.1016\/j.phymed.2025.156651_bib0022","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults - results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regulat. Toxicol. Pharmacol."},{"issue":"11","key":"10.1016\/j.phymed.2025.156651_bib0023","doi-asserted-by":"crossref","first-page":"9924","DOI":"10.1039\/D0FO02152K","article-title":"Green tea polyphenol epigallocatechin-3-gallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet","volume":"11","author":"Huang","year":"2020","journal-title":"Food Funct."},{"issue":"3","key":"10.1016\/j.phymed.2025.156651_bib0024","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/cmi.2015.104","article-title":"Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies","volume":"13","author":"Ju","year":"2016","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156651_bib0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2013.08.031","article-title":"Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions","volume":"342","author":"Kochi","year":"2014","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.phymed.2025.156651_bib0026","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.156651_bib0027","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3389\/fphar.2018.01366","article-title":"EGCG reduces obesity and white adipose tissue gain partly through AMPK activation in mice","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.156651_bib57","doi-asserted-by":"crossref","first-page":"156021","DOI":"10.1016\/j.phymed.2024.156021","article-title":"Paeoniflorin inhibited GSDMD to alleviate ANIT-induced cholestasis via pyroptosis signaling pathway","volume":"134","author":"Ma","year":"2024","journal-title":"Phytomedicine"},{"issue":"13","key":"10.1016\/j.phymed.2025.156651_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310737","article-title":"The potential role of epigallocatechin-3-gallate (EGCG) in breast cancer treatment","volume":"24","author":"Mar\u00edn","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.phymed.2025.156651_bib0029","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mce.2012.04.013","article-title":"The role of angiotensin II in nonalcoholic steatohepatitis","volume":"378","author":"Matthew Morris","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"issue":"3","key":"10.1016\/j.phymed.2025.156651_bib0030","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1039\/C7FO01554B","article-title":"EGCG evokes Nrf2 nuclear translocation and dampens PTP1B expression to ameliorate metabolic misalignment under insulin resistance condition","volume":"9","author":"Mi","year":"2018","journal-title":"Food Funct."},{"issue":"3","key":"10.1016\/j.phymed.2025.156651_bib0031","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open. Med."},{"issue":"5","key":"10.1016\/j.phymed.2025.156651_bib0032","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/oby.2008.10","article-title":"Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance","volume":"16","author":"Raffaella","year":"2008","journal-title":"Obesity"},{"issue":"9","key":"10.1016\/j.phymed.2025.156651_bib0033","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.156651_bib0034","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.phymed.2025.156651_bib0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1039\/c0fo00155d","article-title":"(-)-Epigallocatechin-3-gallate increases the expression of genes related to fat oxidation in the skeletal muscle of high fat-fed mice","volume":"2","author":"Sae-Tan","year":"2011","journal-title":"Food Funct."},{"issue":"11","key":"10.1016\/j.phymed.2025.156651_bib0036","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jnutbio.2015.07.002","article-title":"Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice","volume":"26","author":"Santamarina","year":"2015","journal-title":"J. Nutr. Biochem."},{"issue":"12","key":"10.1016\/j.phymed.2025.156651_bib0037","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","article-title":"Apoptosis and necroptosis in the liver: a matter of life and death","volume":"15","author":"Schwabe","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.phymed.2025.156651_bib0038","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic Steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMa"},{"key":"10.1016\/j.phymed.2025.156651_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.609378","article-title":"Epigallocatechin gallate during dietary restriction - potential mechanisms of enhanced liver injury","volume":"11","author":"Shi","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.phymed.2025.156651_bib0040","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2025.156651_bib0041","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1186\/2193-1801-2-690","article-title":"(-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis","volume":"2","author":"Sumi","year":"2013","journal-title":"Springerplus"},{"issue":"1","key":"10.1016\/j.phymed.2025.156651_bib0042","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3892\/ijmm_00000200","article-title":"Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue","volume":"24","author":"Ueno","year":"2009","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.phymed.2025.156651_bib0043","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3164\/jcbn.18-116","article-title":"Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice","volume":"65","author":"Ushiroda","year":"2019","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"5","key":"10.1016\/j.phymed.2025.156651_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24050954","article-title":"Inhibitory effects of (-)-epigallocatechin-3-gallate on esophageal cancer","volume":"24","author":"Wang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2025.156651_bib0045","article-title":"Epigallocatechin-3-gallate: a phytochemical as a promising drug candidate for the treatment of Parkinson's disease","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.phymed.2025.156651_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/nu12072141","article-title":"Baseline HOMA IR and circulating FGF21 levels predict NAFLD improvement in patients undergoing a low carbohydrate dietary intervention for weight loss: a prospective observational pilot study","volume":"12","author":"Watanabe","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.phymed.2025.156651_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155408","article-title":"Therapeutic effects of epigallocatechin-3-gallate for inflammatory bowel disease: a preclinical meta-analysis","volume":"128","author":"Wei","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.156651_bib0048","article-title":"Epigallocatechin-3-gallate alleviates high-fat diet-induced nonalcoholic fatty liver disease via inhibition of apoptosis and promotion of autophagy through the ROS\/MAPK signaling pathway","volume":"2021","author":"Wu","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"issue":"18","key":"10.1016\/j.phymed.2025.156651_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/nu14183756","article-title":"Epigallocatechin-3-gallate improves intestinal gut microbiota homeostasis and ameliorates clostridioides difficile infection","volume":"14","author":"Wu","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.phymed.2025.156651_bib0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","article-title":"Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1, and NF-kappa B pathways","volume":"53","author":"Xiao","year":"2014","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.phymed.2025.156651_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.784354","article-title":"Caffeine and EGCG alleviate high-trans fatty acid and high-carbohydrate diet-induced NASH in mice: commonality and specificity","volume":"8","author":"Xin","year":"2021","journal-title":"Front. Nutr."},{"issue":"Pt A","key":"10.1016\/j.phymed.2025.156651_bib0052","article-title":"Protective effects of scutellaria-coptis herb couple against non-alcoholic steatohepatitis via activating NRF2 and FXR pathways in vivo and in vitro","volume":"318","author":"Xue","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.phymed.2025.156651_bib0053","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/ptr.6295","article-title":"Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats","volume":"33","author":"Yang","year":"2019","journal-title":"Phytother Res."},{"issue":"7","key":"10.1016\/j.phymed.2025.156651_bib0054","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/labinvest.3700425","article-title":"The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells","volume":"86","author":"Yumei","year":"2006","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.phymed.2025.156651_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13098-022-00823-y","article-title":"Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21-AMPK pathway in mice fed a high fat diet","volume":"14","author":"Zhang","year":"2022","journal-title":"Diabetol. Metab. Syndr."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325002910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325002910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:48:53Z","timestamp":1773352133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325002910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":57,"alternative-id":["S0944711325002910"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156651","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evidence construction for epigallocatechin-3-gallate against non-alcoholic fatty liver disease: a meta-analysis and machine learning study","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156651"}}